4:
A strategy of retrograde injection of bone marrow mononuclear cells into the myocardium for the treatment of ischemic heart disease.
Yokoyama S, Fukuda N, Li Y, Hagikura K, Takayama T, Kunimoto S, Honye J, Saito S, Wada M, Satomi A, Kato M, Mugishima H, Kusumi Y, Mitsumata M, Murohara T.
J Mol Cell Cardiol. 2006 Jan;40(1):24-34. Epub 2005 Nov 4.
PMID: 16271723 [PubMed - indexed for MEDLINE]
Related Articles
5:
Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines.
Kamihata H, Matsubara H, Nishiue T, Fujiyama S, Tsutsumi Y, Ozono R, Masaki H, Mori Y, Iba O, Tateishi E, Kosaki A, Shintani S, Murohara T, Imaizumi T, Iwasaka T.
Circulation. 2001 Aug 28;104(9):1046-52.
PMID: 11524400 [PubMed - indexed for MEDLINE]
Related Articles
13:
Implantation of BM cells transfected with phVEGF165 enhances functional improvement of the infarcted heart.
Xu HX, Li GS, Jiang H, Wang J, Lü JJ, Jiang W, Qian HY, Jiang XJ, Li XY, Li JJ, Liu WH.
Cytotherapy. 2004;6(3):204-11.
PMID: 15203977 [PubMed - indexed for MEDLINE]
Related Articles